These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 851480)
21. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta. Borden EC; Sidky YA; Hatcher JF; Bryan GT Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000 [TBL] [Abstract][Full Text] [Related]
22. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice. Fenton MR; Havas HF J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719 [TBL] [Abstract][Full Text] [Related]
23. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine. Cohen MH J Pharmacol Exp Ther; 1975 Sep; 194(3):475-9. PubMed ID: 240017 [TBL] [Abstract][Full Text] [Related]
24. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334 [TBL] [Abstract][Full Text] [Related]
25. Rationale for development of platinum analogs. Burchenal JH; Kalaher K; Dew K; Lokys L Cancer Treat Rep; 1979; 63(9-10):1493-8. PubMed ID: 498148 [TBL] [Abstract][Full Text] [Related]
26. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486. Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521 [TBL] [Abstract][Full Text] [Related]
27. Chemotherapy and radiation therapy of human medulloblastoma in athymic nude mice. Friedman HS; Schold SC; Varia M; Bigner DD Cancer Res; 1983 Jul; 43(7):3088-93. PubMed ID: 6850617 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic studies of a transplantable murine renal adenocarcinoma. Sufrin G; Murphy GP Invest Urol; 1977 Jul; 15(1):9-14. PubMed ID: 68945 [TBL] [Abstract][Full Text] [Related]
29. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice. Zaharko D; Plowman J; Waud W; Dykes D; Malspeis L Cancer Res; 1992 Jul; 52(13):3604-9. PubMed ID: 1617631 [TBL] [Abstract][Full Text] [Related]
30. The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma. Corso A; Barbarano L; Zappasodi P; Cairoli R; Alessandrino EP; Mangiacavalli S; Ferrari D; Fava S; Fiumanò M; Frigerio G; Isa L; Luraschi A; Klersy C; De Paoli A; Vergani C; Banfi L; Perego D; Ucci G; Pinotti G; Savarè M; Uziel L; Vismara A; Morra E; Lazzarino M Haematologica; 2004 Sep; 89(9):1124-7. PubMed ID: 15377474 [TBL] [Abstract][Full Text] [Related]
31. [Nonspecific oxidase activity in the liver of rats undergoing chemotherapy with cis-dichlorodiammineplatinum]. Kulik GI; Pel'kis FP; Chekhun VF; Sidorik OA; Boĭm TM Eksp Onkol; 1984; 6(6):60-3. PubMed ID: 6543174 [TBL] [Abstract][Full Text] [Related]
32. [Complex compounds of platinum in the chemotherapy of malignant tumors]. Presnov MA; Konovalova AL; Korol'chuk VP Vestn Akad Med Nauk SSSR; 1979; (2):68-80. PubMed ID: 105504 [No Abstract] [Full Text] [Related]
33. [Results of drug sensitivity test of UFT, doxorubicin and cisplatin using human urogenital cancers transplanted subcutaneously into nude mice]. Murahashi I; Hosoya Y; Mukae K; Honda M; Takasaki E Gan To Kagaku Ryoho; 1988 Nov; 15(11):3059-65. PubMed ID: 3142366 [TBL] [Abstract][Full Text] [Related]
34. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations. Schold SC; Friedman HS; Bjornsson TD; Bigner DD Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774 [TBL] [Abstract][Full Text] [Related]
35. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice. Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085 [TBL] [Abstract][Full Text] [Related]
36. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness. Morstyn G; Schechter GP; Ihde DC; Carney DN; Eddy JL; Cohen MH; Minna JD; Bunn PA Cancer Treat Rep; 1984 Dec; 68(12):1439-46. PubMed ID: 6391662 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo. Harrison SD; Stevens JJ; Waud WR; Dykes DJ; Schmid SM; Griswold DP J Biol Response Mod; 1990 Aug; 9(4):395-400. PubMed ID: 2118561 [TBL] [Abstract][Full Text] [Related]
38. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys. Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844 [TBL] [Abstract][Full Text] [Related]
39. Novel bifunctional anthracycline and nitrosourea chemotherapy for human bladder cancer: analysis in a preclinical survival model. Glaves D; Murray MK; Raghavan D Clin Cancer Res; 1996 Aug; 2(8):1315-9. PubMed ID: 9816302 [TBL] [Abstract][Full Text] [Related]
40. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]